Form4insider filings, from the source

SEC Form 3 · accession 0001213900-26-102340

Inmune Bio, Inc. · INMB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 8, 2026
Accepted (ET)
Sep 23, 2026 · 6:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711754

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

No Table II lines on this filing.